Assessing Frailty, Rational Use of Medications, and Adherence to Immunosuppressive Therapy in Liver Transplant Recipients

Basit Öğe Kaydı
dc.contributor.authorKormurkara, Sema
dc.contributor.authorCengiz, Zeliha
dc.contributor.authorTok, Sedef
dc.date.accessioned2026-04-04T13:34:46Z
dc.date.available2026-04-04T13:34:46Z
dc.date.issued2024
dc.departmentİnönü Üniversitesi
dc.description.abstractAim. The study was conducted to determine the level of frailty, rational medication use, and adherence to immunosuppressive therapy in liver transplant patients and to examine the relationships among them. Materials and Methods. The data of the descriptive cross-sectional study were collected between January 2023 and September 2023. Our study included 200 liver transplant recipients. In addition to demographic and medical characteristics, frailty status, rational drug use, and compliance with immunosuppressive therapy were measured in a 15-20 - 20 minute questionnaire administration period. Results. The frailty scores of liver transplant patients were 2.11 1.34, rational drug use scores were 82.88 13.11, and compliance with immunosuppressive therapy scores were 11.12 1.07. The scores for rational drug use and adherence to immunosuppressive therapy were not affected by frailty status, and patients used drugs rationally and adhered to immunosuppressive therapy even when they were frail. It was found that the vulnerability status of the participants was affected by gender and occupational variables, most patients were in the vulnerable group in women and men, and those who did not work were more vulnerable than the other groups. Conclusion. It was found that liver transplant patients were frail, and frailty did not affect the level of rational drug use and compliance with immunosuppressive therapy.
dc.identifier.doi10.1016/j.transproceed.2024.08.041
dc.identifier.endpage1789
dc.identifier.issn0041-1345
dc.identifier.issn1873-2623
dc.identifier.issue8
dc.identifier.orcid0000-0002-3819-1717
dc.identifier.orcid0009-0000-3282-6171
dc.identifier.pmid39244449
dc.identifier.scopus2-s2.0-85203265408
dc.identifier.scopusqualityQ3
dc.identifier.startpage1784
dc.identifier.urihttps://doi.org/10.1016/j.transproceed.2024.08.041
dc.identifier.urihttps://hdl.handle.net/11616/109397
dc.identifier.volume56
dc.identifier.wosWOS:001318390400001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofTransplantation Proceedings
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250329
dc.subjectOutcomes
dc.titleAssessing Frailty, Rational Use of Medications, and Adherence to Immunosuppressive Therapy in Liver Transplant Recipients
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu